Roger J. Pomerantz

Roger J. Pomerantz, MD, FACP, is a distinguished figure in the biotechnology and pharmaceutical sectors with extensive leadership experience. Currently serving as Vice Chairman of the Board at Enlivex Therapeutics, Pomerantz also holds key positions as Founding Chairman at Indaptus Therapeutics and VerImmune, and Chairman of the Board at Viracta Therapeutics and CollPlant. With a longstanding association with Seres Therapeutics as Senior Clinical Advisor and past roles including President, CEO, and Chairman of ContraFect Corp, Pomerantz has significantly contributed to advancements in immuno-oncology, infectious diseases, and regenerative medicine. Educational credentials include a Doctor of Medicine from The Johns Hopkins University School of Medicine, along with postdoctoral training at the Massachusetts Institute of Technology and multiple positions at Harvard Medical School and Massachusetts General Hospital.